Acusensus Statistics
Total Valuation
Acusensus has a market cap or net worth of AUD 284.47 million. The enterprise value is 250.92 million.
| Market Cap | 284.47M |
| Enterprise Value | 250.92M |
Important Dates
The last earnings date was Wednesday, February 25, 2026.
| Earnings Date | Feb 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Acusensus has 168.32 million shares outstanding. The number of shares has increased by 11.23% in one year.
| Current Share Class | 168.32M |
| Shares Outstanding | 168.32M |
| Shares Change (YoY) | +11.23% |
| Shares Change (QoQ) | +1.96% |
| Owned by Insiders (%) | 13.34% |
| Owned by Institutions (%) | 17.11% |
| Float | 111.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.02 |
| PB Ratio | 5.07 |
| P/TBV Ratio | 5.08 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 87.39 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -10.94 |
| EV / Sales | 3.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -18.49 |
Financial Position
The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.13.
| Current Ratio | 1.79 |
| Quick Ratio | 1.73 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 18.76 |
| Debt / FCF | -0.55 |
| Interest Coverage | -19.95 |
Financial Efficiency
Return on equity (ROE) is -44.11% and return on invested capital (ROIC) is -29.14%.
| Return on Equity (ROE) | -44.11% |
| Return on Assets (ROA) | -5.00% |
| Return on Invested Capital (ROIC) | -29.14% |
| Return on Capital Employed (ROCE) | -9.77% |
| Weighted Average Cost of Capital (WACC) | 2.47% |
| Revenue Per Employee | 271,429 |
| Profits Per Employee | -87,839 |
| Employee Count | 261 |
| Asset Turnover | 0.86 |
| Inventory Turnover | 22.42 |
Taxes
| Income Tax | -733,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +47.60% in the last 52 weeks. The beta is -0.29, so Acusensus's price volatility has been lower than the market average.
| Beta (5Y) | -0.29 |
| 52-Week Price Change | +47.60% |
| 50-Day Moving Average | 1.68 |
| 200-Day Moving Average | 1.36 |
| Relative Strength Index (RSI) | 48.70 |
| Average Volume (20 Days) | 257,134 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Acusensus had revenue of AUD 70.84 million and -22.93 million in losses. Loss per share was -0.17.
| Revenue | 70.84M |
| Gross Profit | 29.36M |
| Operating Income | -6.56M |
| Pretax Income | -23.66M |
| Net Income | -22.93M |
| EBITDA | -2.46M |
| EBIT | -6.56M |
| Loss Per Share | -0.17 |
Balance Sheet
The company has 40.96 million in cash and 7.41 million in debt, with a net cash position of 33.55 million or 0.20 per share.
| Cash & Cash Equivalents | 40.96M |
| Total Debt | 7.41M |
| Net Cash | 33.55M |
| Net Cash Per Share | 0.20 |
| Equity (Book Value) | 56.06M |
| Book Value Per Share | 0.35 |
| Working Capital | 25.46M |
Cash Flow
In the last 12 months, operating cash flow was 3.26 million and capital expenditures -16.82 million, giving a free cash flow of -13.57 million.
| Operating Cash Flow | 3.26M |
| Capital Expenditures | -16.82M |
| Free Cash Flow | -13.57M |
| FCF Per Share | -0.08 |
Margins
Gross margin is 41.44%, with operating and profit margins of -9.26% and -32.36%.
| Gross Margin | 41.44% |
| Operating Margin | -9.26% |
| Pretax Margin | -33.40% |
| Profit Margin | -32.36% |
| EBITDA Margin | -3.48% |
| EBIT Margin | -9.26% |
| FCF Margin | n/a |
Dividends & Yields
Acusensus does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.23% |
| Shareholder Yield | -11.23% |
| Earnings Yield | -8.06% |
| FCF Yield | -4.77% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 27, 2023. It was a forward split with a ratio of 5.
| Last Split Date | Jul 27, 2023 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
Acusensus has an Altman Z-Score of 2.76 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.76 |
| Piotroski F-Score | 2 |